{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:39:39Z","timestamp":1676439579253},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":184,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/bjd.13664","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T03:46:21Z","timestamp":1426563981000},"page":"564-565","source":"Crossref","is-referenced-by-count":5,"title":["To (anti-)TNF or not (anti-)TNF? That is the question in pemphigus"],"prefix":"10.1093","volume":"172","author":[{"given":"A.A.","family":"Sinha","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of Buffalo; 875 Ellicott Street 6082 Clinical and Translational Research Center Buffalo NY U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"10.1111\/bjd.13664-BIB0001|bjd13664-cit-0001","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1111\/bjd.13664-BIB0002|bjd13664-cit-0002","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13664-BIB0003|bjd13664-cit-0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13664-BIB0004|bjd13664-cit-0004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/08916934.2012.697593","article-title":"Cytokine networks in pemphigus vulgaris: an integrated viewpoint","volume":"45","author":"Giordano","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1111\/bjd.13664-BIB0005|bjd13664-cit-0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13664-BIB0006|bjd13664-cit-0006","first-page":"245","article-title":"Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept","volume":"74","author":"Berookhim","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/bjd.13664-BIB0007|bjd13664-cit-0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2005.06672.x","article-title":"Infliximab in the management of severe pemphigus vulgaris","volume":"153","author":"Pardo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13664-BIB0008|bjd13664-cit-0008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2133.2005.06744.x","article-title":"Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab","volume":"153","author":"Jacobi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13664-BIB0009|bjd13664-cit-0009","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archderm.141.6.680","article-title":"Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser","volume":"141","author":"Lin","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13664-BIB0010|bjd13664-cit-0010","first-page":"940","article-title":"Successful treatment of pemphigus vulgaris with etanercept in four patients","volume":"8","author":"Shetty","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13664-BIB0011|bjd13664-cit-0011","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjd.13350","article-title":"A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone","volume":"172","author":"Hall","year":"2015","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13664","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13664\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:13:41Z","timestamp":1676384021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/3\/564\/6615864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13664","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}